NCT01367483View on ClinicalTrials.gov

Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Healthy Male Volunteers
Interventions
DRUG

IV methylnaltrexone (MNTX)

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367483 - Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX | Biotech Hunter | Biotech Hunter